TC
LABU icon

Truvestments Capital’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Truvestments Capital’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5
Closed -$3K – 379
2019
Q3 		$3K Hold
5
– – ﹤0.01% 636
2019
Q2 		$5K Buy
+5
New +$4.84K ﹤0.01% 616

Other funds holding LABU

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Truvestments Capital's LABU Position: Q4 2019 in Review

Truvestments Capital sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2019, closing a stake of 5 shares — an estimated $3K sold.

Truvestments Capital first reported a position in LABU in Q2 2019 and held it in 2 quarters. The position peaked at $5K in Q2 2019. 22 funds tracked by Wall St. Rank hold LABU as of Q4 2019.

  • Truvestments Capital reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2019 after selling out during the quarter.
  • Truvestments Capital sold 5 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2019, an estimated $3K.
  • Truvestments Capital first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2019 and held it in 2 quarters.
  • Truvestments Capital's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $5K in Q2 2019.
  • 22 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2019.

Based on Truvestments Capital's 13F filing for Q4 2019, filed 29 Jan 2020.